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Abstract We have previously reported that in C3H/10T1/2 
fibroblasts the environmental carcinogen 7,12-dimethyl- 
benz[a]anthracene (DMBA) stimulated phosphorylation of etha- 
nolamine (Etn). Here we show that in these fibroblasts DMBA 
also stimulates phosphorylation of choline (Cho). Wortmannin 
(50-200 nM), an established inhibitor of phosphatidylinositol-3- 
kinase (P13K), significantly inhibited DMBA-induced phospho- 
rylation of both Etn and Cho. Wortmannin also inhibited the 
effect of insulin, a major activator of PI3K, on DNA synthesis. 
However, insulin had no effect on the phosphorylation of Etn and 
Cho. These data suggest hat a carcinogen-induced kinase phos- 
phorylates both Etn and Cho, and that the inhibitory effect of 
wortmannin on Etn/Cho kinase activity may be unrelated to its 
inhibitory effect on PI3K activity. 
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1. Introduction 
Virtually all human tumors examined so far contain high 
concentrations of phosphomonoesters mostly represented by 
either ethanolamine phosphate (EtnP) or choline phosphate 
(ChoP), or both (referenced in [1]). This suggests a causal rela- 
tionship between high cellular levels ofphosphomonoesters and
altered cell growth. Two recent observations further strengthen 
this possibility. Thus, Cuadrado et al. [2] recently reported that 
formation of ChoP represents a key step during mitogenic stim- 
ulation of cells by several growth factors. We also reported [1] 
that in C3H/10TI/2 fibroblasts, a frequently used cellular 
model of chemical carcinogenesis [3-5], chemical carcinogens 
relatively rapidly stimulated both Etn formation from 
phosphatidylethanolamine (PtdEtn), and subsequent phospho- 
rylation of Etn by a kinase activity. This latter finding is of 
considerable interest because it may not only reveal a possible 
role for EtnP in cell growth regulation, but it may also have 
prognostic value. For these reasons we have a continuous inter- 
est in the characterization of carcinogen effects on the phospho- 
rylation of Etn and Cho. 
When fibroblasts were labeled with [~4C]Etn or [14C]Cho for 
48 h, followed by treatments of subconfluent cultures with 
7,12-dimethylbenz[a]anthracene (DMBA) for the last 24 h of 
the labeling period, we observed significant carcinogen-induced 
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increases in the cellular level of [J4C]EtnP, but not that of 
[14C]ChoP [1]. This could mean that these cells possessed a
carcinogen-inducable Etn-specific kinase activity. However, 
carcinogens also stimulated PtdEtn hydrolysis while they de- 
creased PtdCho hydrolysis [6]. Thus, it was also possible that 
a carcinogen-stimulated kinase phosphorylates both Etn and 
Cho, but it preferentially uses substrates, presently Etn, derived 
from increased phospholipid hydrolysis. Finally, the Etn- and 
Cho-phosphorylating system(s) may respond to carcinogens 
differently when fibroblasts are present in the growing or non- 
growing phases. In order to distinguish among these possibili- 
ties, here we compared the effects of carcinogen treatment on 
the phosphorylation f Cho and Etn in confluent cultures. The 
results clearly indicate that in these fibroblasts, DMBA has 
comparable stimulatory effects on the phosphorylation of
~4C-labeled Etn and Cho added to the medium. 
Wortmannin is thought to be a specific inhibitor of 
phosphatidylinositol-3-kinase (pI3K) [6-8]. Here we also exam- 
ined the effects of wortmannin on the phosphorylation f Etn 
and Cho. The results how that wortmannin hibits phospho- 
rylation of both Etn and Cho. 
2. Experimental 
2.1. Materials 
DMBA, wortmannin, Etn and Dowex-50W (H ÷ form) were pur- 
chased from Sigma; insulin was from Boehringer Mannheim; [2- 
t4C]ethanolamine (55 mCi/mmol), [methyl-lnC]choline (50 mCi/mmol) 
and [methyL3H]thymidine (85 mCi/mmol) were bought from Amer- 
sham; tissue culture reagents were from Gibco-BRL. 
2.2. Cell culture 
The C3H/10T1/2 embryonal fibroblast line was from American Type 
Culture Collection and was maintained inbasal Eagle's medium supple- 
mented with 10% fetal calf serum (heat-inactivated). Cells were used 
between passages 10-14. The NIH 3T3 clone-7 fibroblast line was 
kindly provided by Dr. Douglas R. Lowy (National Cancer Institute, 
National Institutes of Health, Bethesda, Maryland, U.S.A.). NIH 3T3 
fibroblasts were continuously cultured in Dulbeceo's Modified Eagle's 
medium supplemented with 10% fetal calf serum, penicillin (50 units/ 
ml)/streptomycin (50pl/ml), and glutamine (2 mM). 
2.3. Determination of cellular uptake and phosphorylation of [14C]Etn 
and [14C]Cho in fibroblasts 
Fibroblasts were grown in 12-well tissue culture dishes to confluency 
and then either emained untreated or were treated with DMBA (0.5 
pg/ml) for 24 h. When indicated, wortmannin was added for the last 
hour of incubation. This was followed (with no washing step being 
included) by incubations of fibroblasts for 1 3 h in the presence of 
50,uM [t4C]Etn (802,000-991,000 dpm/well) or 50 ,uM [14C]Cho 
(1.23 × l06 - 1.28 × 106 dpm/well). At the conclusion of incubations, the 
incubation medium was aspirated, then fibroblasts were rapidly (within 
20 s) washed with 5 ml medium followed by the addition of ice-cold 
methanol (2 ml) to the wells; this was followed by scraping of cells into 
methanol, and by rapid transfer of methanol extracts to tubes contain- 
ing chloroform. After phase separation, the water-soluble d rivatives 
of [14C]Etn and [~4C]Cho were separated on Dowex-50W (H ÷) columns 
0014-5793/95l$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(94)01434-5 
244 Z. Kiss, M. Tomono/FEBS Letters 358 (1995) 243-246 
as previously described [6]. The 14C activity in phospholipids was deter- 
mined as previously indicated [6]. 
2.4. Labeling of cellular DNA with [3H]thymidine 
NIH 3T3 fibroblasts were grown in 12-well tissue culture dishes to 
about 40-50% confluency in the presence of 10% serum. This was 
followed by incubation of fibroblasts in serum-free medium for 24 h, 
and then by treatments with insulin and/or wortmannin for 16 h. Fi- 
nally, incubations were continued inthe presence of[methyl-3H]thymid - 
ine (5/2Ci/ml) for 60 min. Fibroblasts were washed twice with phos- 
phate-buffered saline and then four times with 5% trichloroacetic a id. 
The acid-insoluble material was redissolved in 0.3 M sodium hydroxide, 
and an aliquot was taken to measure DNA-associated 3H-activity ina 
liquid scintillation counter. 
3. Results 
In a previous work, the effects of carcinogens on the phos- 
phorylation of Etn were examined in subconfluent cultures of 
C3H/10T1/2 fibroblasts. In these fibroblasts, phosphorylation 
of Etn occurred at a relatively high rate and an optimal concen- 
tration (0.5/lg/ml) of DMBA enhanced EtnP formation about 
2-fold [1]. Since then, we performed a more detailed examina- 
tion of phosphorylation f Etn at various tages of confluency. 
In unstimulated confluent cultures, the rate of Etn phosphoryl- 
ation was lower than in subconfluent cultures, but carcinogens 
elicited signifcantly greater stimulation of Etn kinase activity 
in the former cells. Thus, in this work the effects of DMBA and 
wortmannin on the phosphorylation f Etn and Cho were de- 
termined in confluent cultures. 
When confluent C3H/10T1/2 fibroblasts were incubated in 
the presence of [14C]Etn, in untreated fibroblasts (A) and in 
fibroblasts treated with DMBA (0.5/.tg/ml) for 24 h (B), the 
increase in the cellular content of [~4C]Etn reached a plateau 
after I-2 h incubation. During the first hour of incubation, 
50-200 nM concentrations of wortmannin appeared to slightly 
enhance the cellular content of [~4C]Etn (Fig. 1A and IB), but 
this compound clearly had no inhibitory effect at any time 
interval examined. Untreated fibroblasts accumulated about 
twice more [~4C]EtnP (Fig. 1C) than [~4C]Etn (Fig. 1A) by the 
end of the 3 h incubation period. Although in this presentation 
it is somewhat difficult to observe, 50-200 nM concentrations 
of wortmannin caused 16-28% inhibition of [14C]EtnP forma- 
tion in non-DMBA-treated fibroblasts (Fig. 1C); this small 
inhibition was reflected in decreased ~4C-labeling of PtdEtn 
(Fig. 1E). In DMBA-treated fibroblasts (Fig. 1D) the rate of 
[14C]EtnP formation at various incubation times was 4.2- to 
6.4-fold greater compared to untreated fibroblasts (Fig. 1C]. 
200 nM Wortmannin i hibited [laC]EtnP formation by 24, 45 
and 51% after 1, 2 and 3 h incubation, respectively (Fig. 1D). 
It should be noted that 50 nM wortmannin was almost as 
effective as 200 nM wortmannin inhibiting phosphorylation 
of Etn (Fig. 1D), while an increase of concentration f wort- 
mannin above 200 nM did not cause additional inhibition (data 
not shown). Despite the large increase in [14C]EtnP formation 
in DMBA-treated fibroblasts, incorporation of [14C]Etn into 
PtdEtn was only slightly different in the untreated (Fig. 1E) and 
DMBA-treated fibroblasts (Fig. IF). Also, wortmannin simi- 
larily inhibited the formation of [L4C]PtdEtn in the untreated 
and DMBA-treated fibroblasts. 
The effect of DMBA on the metabolism of [14C]Cho was very 
similar to its effect on [~4C]Etn metabolism. Thus, both in the 
untreated (Fig. 2A) and DMBA-treated fibroblasts (Fig. 2B), 
30 
"i ~ 25 
"~ ~.  x 15 
EO-IO 
v 
5 
0 
0 
C D 
E 
1 2 3 
5 
ix. ~ 3 G'= 
1 
F 
1 2 3 
Incubation time [ hours ] 
Fig. 1. Effects of DMBA and wortmannin on the uptake and metabo- 
lism of [~4C]Etn i  C3H/10TI/2 fibroblasts. Fibroblasts, grown in 12- 
well culture dishes up to confluency, were untreated (A,C,E), or were 
treated for 23 h with 0.5 ktg/ml of DMBA (B,D,F). This was followed 
by incubation (without removing DMBA) of fibroblasts for 1 h in the 
absence (o) or presence of 50 nM (A) or 200 nM (m) wortmannin. At 
this time point, each well received (without removing DMBA/wortman- 
nin) [~4C]Etn (50/~M; 991,000 dpm/well), and incubations continued for 
up to 3 h. Incorporation of exogenous [14C]Etn into the cellular pool 
of [14C]Etn (A,B), [14C]EtnP (C,D) and [14C]PtdEtn (E,F) were 
determined as described in section 2. Each point represents he 
mean + S.E.M. of eight independent i cubations. 
the increase in the cellular content of [m4C]Cho reached a pla- 
teau after 2 h incubation. In both untreated and DMBA-treated 
fibroblasts, addition ofwortmannin slightly enhanced the cellu- 
lar content of [~4C]Cho. In DMBA-treated fibroblasts (Fig. 
2D), the rate of [~4C]ChoP formation at increasing incubation 
times was 3.9- to 10.1-fold higher than in untreated fibroblasts 
(Fig. 2C). Also, 50~00 nM concentrations of wortmannin - 
hibited the formation of [lnC]ChoP both in the untreated (Fig. 
2C) and DMBA-treated fibroblasts (Fig. 2D) to similar extents, 
as it was observed in the case of [laC]EtnP formation. Again, 
despite the large stimulatory effects of DMBA on [~4C]ChoP 
formation, incorporation of [14C]Cho into PtdCho occurred to 
similar extents in the untreated (Fig. 2E) and DMBA-treated 
fibroblasts (Fig. 2F). Furthermore, wortmannin similarly in- 
hibited the formation of [~4C]PtdCho in the untreated and 
DMBA-treated fibroblasts. We should add here that treatment 
of subconfluent cultures with DMBA resulted in about 1.5- to 
2.4-fold stimulation of [14C]ChoP formation over a 3 h incuba- 
tion period (data not shown). 
Previously, a treatment of subconfluent [~4C]Etn-labeled fi- 
broblasts with DMBA for 24 h enhanced the cellular level of 
[14C]EtnP about 2-fold, but DMBA caused no significant in- 
crease in the cellular level of [laC]ChoP [1]. We repeated this 
experiment with confluent ~4C-labeled C3H/10TI/2 fibroblasts 
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Fig. 2. Effects of DMBA and wortmannin on the uptake and metabo- 
lism of [~4C]Cho in C3H/10T1/2 fibroblasts. The schedule of treatment 
of confluent fibroblast cultures with DMBA and wortmannin was the 
same as described inlegend to Fig. 1. Untreated (A,C,E) and DMBA- 
treated (B,D,F) fibroblasts were incubated inthe presence of[J4C]Cho 
(50/.tM; 1.28 x 106 dprrdwell) for up to 3 h. During the labeling period, 
wortmannin was not present (e), or it was present at 50 nM (4) or 
200 nM (w) concentration. I corporation of exogenous [~4C]Cho into 
the cellular pool of [~4C]Cho (A,B), [~4C]ChoP (C,D) and [14C]PtdCho 
(E,F) were determined asdescribed insection 2. Each point represents 
the mean _+ S.E.M. of eight independent i cubations. 
and found that treatments with 0.5/.tg/ml of DMBA for 24 h 
enhanced the cellular levels of [14C]EtnP and [14C]ChoP 3.9- and 
1.8-fold, respectively (data not shown). Thus, in confluent fi- 
broblasts, increased formation of [14C]EtnP remained the dom- 
inant long-term effect of DMBA. 
The ability of wortmannin to inhibit phosphorylation f Etn 
and Cho, both in untreated and DMBA-treated C3H/10T1/2 
fibroblasts, would be consistent with a direct effect of this drug 
on the respective kinase activity. However, in confluent 
NIH3T3 fibroblasts, wortmannin failed to inhibit phosphoryla- 
tion of either Etn or Cho (Fig. 3A). On the other hand, a 
treatment of these fibroblasts with DMBA enhanced the rate 
of phosphorylation f both [~4C]Etn and [14C]Cho about 2.4- to 
2.6-fold, and these effects of DMBA were significantly (by 
31-33%) inhibited by 200 nM wortmannin (Fig. 3B). Clearly, 
wortmannin could not directly affect the activity of Etn/Cho 
kinase. 
At the concentrations u ed here, wortmannin has been re- 
ported to be a specific inhibitor of PI3K [7]. Thus, this enzyme 
may well regulate Etn/Cho kinase activity establishing a direct 
link between the inhibitory effects of wortmannin on the activ- 
ity of PI3K and phosphorylation f Etn/Cho. Insulin is a major 
activator of PI3K (referenced in [8]) and PI3K appears to play 
a role in the mediation of mitogenic effects of insulin [8]. In 
accordance with such mechanisms, we also found that in NIH 
3T3 fibroblasts, wortmannin suppressed the stimulatory effect 
of insulin on DNA synthesis (Fig. 4). In these fibroblasts, the 
stimulatory effect of insulin on DNA synthesis can be enhanced 
by 1 mM Etn. While the mechanism of the potentiating effect 
of Etn remains to be determined, the large combined stimula- 
tory effects of insulin plus Etn were also greatly inhibited by 
wortmannin (Fig. 4). However, using similar conditions, we 
could not observe an insulin effect on the phosphorylation f 
either Etn or Cho (data not shown). 
4. Discuss ion 
The first major finding of this work was that the chemical 
carcinogen DMBA stimulated phosphorylation f not only Etn 
but also that of Cho. After a 3 h labeling period, a preceding 
DMBA treatment for 24 h enhanced the phosphorylation f 
[14C]Cho and [14C]Etn about 10.1- and 6.4-fold, respectively. 
Despite the greater effect of DMBA on the phosphorylation f 
Cho added to the medium, a longer-term (24 h) treatment of 
14C-labeled fibroblasts with DMBA preferentially enhanced the 
cellular level of [14C]EtnE Two possible mechanisms may ac- 
count for this apparent discrepancy in the results. The effect of 
DMBA on Cho phosphorylation might be more transient com- 
pared to the stimulation of Etn phosphorylation. The other 
possibility is that this kinase, due to the compartmentalization 
of this system, preferentially used Etn and Cho derived from 
phospholipid hydrolysis. In this latter case it would mean pref- 
erential use of Etn, because DMBA increased the formation of 
ethanolamine from PtdEtn, but it decreased the formation of 
choline from PtdCho [6]. We are presently investigating both 
possibilities. Regardless of the exact mechanisms involved, 
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Fig. 3 Effects of DMBA and wortmannin on the formation of [14C]EtnP 
and [~4C]ChoP in NIH 3T3 flbroblasts. Fibroblasts, grown in 12-well 
culture dishes up to confluency, were untreated (A), or were treated for 
23 h with 0.5 pg/ml of DMBA (B). This was followed by incubation 
(without removing DMBA) of fibroblasts for 1 h in the absence (~) or 
presence of 200 nM wortmannin (m). At this time point, each well 
received (without removing DMBA/wortmannin) 50 /tM [14C]Etn 
(802,000 dpm/well) on 50/tM [I4C]Cho (1.23 x 106 dpm/well) and incu- 
bations continued for 2 h. Formation of [14C]EtnP (I) and [14C]ChoP 
(II) was determined as indicated in section 2. Data represent 
the mean _+ S.E.M. of six independent incubations. *Significantly 
(P < 0.01) different from the respective control value (Student's t-test). 
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Fig. 4. Inhibition of insulin-induced DNA synthesis by wortmannin 
NIH 3T3 fibroblasts. Fibroblasts, treated with 500 nM insulin (I) or 500 
nM insulin plus 1 mM Etn (II) were incubated in the presence of 
[3H]thymidine as described insection 2. During the treatment (16 h) and 
labeling (1 h) period, 50 nM wortmannin was either absent ([]) or 
present (a). Data are the mean + S.E.M. of three incubations. The 
effects of ethanolamine and wortmannin were confirmed in two other 
experiments each performed in triplicate. 
however, it is clear that at least in fibroblasts, a longer exposure 
to the carcinogen preferentially enhances the cellular level of 
EtnP, even though the activated kinase phosphorylates both 
Etn and Cho. This may be relevant to other observations indi- 
cating that in several human tumors it is EtnP, and not ChoP, 
whose tissue level is enhanced [9-15]. 
The second major finding of this work was that wortmannin, 
an inhibitor of PI3K [7], also inhibited phosphorylation f both 
Cho and Etn. The fact that wortmannin specifically inhibited 
phosphorylation f [14C]Cho and [14C]Etn without reducing the 
cellular levels of these precursors provide an important proof 
that this drug inhibited the respective kinase activity, and not 
the uptake mechanisms. Furthermore, these data also serve as 
additional evidence that the primary target of DMBA action 
was the Etn/Cho kinase system. On the other hand, it is impor- 
tant to stress that inhibition of kinase activity by wortmannin 
did not result in large increases in the cellular levels of Cho and 
Etn. This suggests hat a higher ate of production of ChoP and 
EtnP by activated kinase is accompanied by stimulated uptake 
of precursors and vice versa. 
Importantly, insulin, a major activator of PI3K [8], failed to 
enhance phosphorylation f Cho or Etn in NIH 3T3 fibrob- 
lasts. A possible interpretation f this result is that the inhib- 
itory effects of wortmannin on the Etn/Cho kinase activity are 
not mediated by PI3K. Alternatively, two cellular pools of 
PI3K may exist; an insulin-sensitive pool of PI3K may not 
regulate, while an insulin-insensitive pool of PI3K may regulate 
Etn/Cho kinase activity. Further work is needed to clarify this 
important issue. 
The inhibitory effect of wortmannin on the activity of Etn/ 
Cho kinase is unlikely to reflect a direct interaction of wort- 
mannin with this enzyme because in untreated NIH 3T3 fibrob- 
lasts this drug failed to inhibit the phosphorylation f Etn and 
Cho. While these latter data indicate that inhibition of this 
kinase activity by wortmannin occurs by an indirect mecha- 
nism, they also indicate that the mechanism which accounts for 
the stimulatory effects of DMBA is partially activated in C3H/ 
10Tl/2 fibroblasts, but not in NIH 3T3 fibroblasts. 
Finally, we should point out that the higher levels of 
[14C]EtnP and [14C]ChoP in DMBA-treated fibroblasts were not 
reflected in increased synthesis of the respective phospholipids. 
Clearly, phosphorylation f ChoP and EtnP is not the rate- 
limiting step in the synthesis of these phospholipids, an obser- 
vation which agrees well with observations from several other 
laboratories (reviewed in refs. 16 and 17). These results indicate 
that if carcinogen-induced synthesis of EtnP and ChoP has 
indeed any role in the transformation process, this is not medi- 
ated by phospholipid synthesis. 
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